CALLODINE CAPITAL MANAGEMENT, LP – Bristol-Myers Squibb Company Transaction History
CALLODINE CAPITAL MANAGEMENT, LP portfolio value:
$11.73M
portfolio value
CALLODINE CAPITAL MANAGEMENT, LP quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +127.59% | 92.5K shares | 6.14M | $71.09 | 165K |
| Q2 2022 | share | Decrease | -71.57% | -182.5K shares | -13.04M | $77 | 72.5K |
| Q1 2022 | share | Decrease | -5.56% | -15K shares | 1.78M | $73.03 | 255K |
| Q4 2021 | share | Decrease | -10.00% | -30K shares | -916K | $62.52 | 270K |
| Q3 2021 | share | Increase | +8.11% | 22.5K shares | -792K | $59.17 | 300K |
| Q2 2021 | share | Increase | +5.71% | 15K shares | 1.97M | $65.79 | 277.5K |
| Q1 2021 | share | Increase | +31.25% | 62.5K shares | 4.16M | $62.15 | 262.5K |
| Q4 2020 | share | Increase | +18.08% | 30.62K shares | 2.19M | $60.6 | 200K |
| Q3 2020 | share | Decrease | -10.86% | -20.62K shares | -960K | $58 | 169.37K |
| Q2 2020 | share | Decrease | -51.90% | -205K shares | -10.84M | $56.14 | 190K |
| Q1 2020 | share | Increase | +27.42% | 85K shares | 2.11M | $52.79 | 395K |
| Q4 2019 | share | Increase | +14.81% | 40K shares | 6.20M | $60.36 | 310K |
| Q3 2019 | share | Increase | +350.00% | 210K shares | 10.97M | $47.3 | 270K |
| Q2 2019 | share | Increase | 0.00% | 60K shares | 2.72M | $41.93 | 60K |